Skip to content

Marksans Pharma spurts to 52-week high on share allotment to promoter

The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia

Read More

​ The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish